Aging is becoming an engineering problem.
Multi-omic biomarkers. Longitudinal datasets at population scale. Foundation models trained on biological aging. Wearables and continuous monitoring feeding clinical-grade signal. Closed-loop intervention platforms. The same compute curve that rewrote software is now rewriting how we measure, model, and intervene on human aging.
Boston is the operating system for this shift. MIT, Harvard, the Broad, the hospital network, and the densest concentration of longevity biotechs on the planet, all within a four-mile radius.
During Boston Tech Week, the Aging Code Summit pulls that stack into one room.
What you will see on stage:
- Principal investigators from MIT and Harvard shipping the science behind epigenetic clocks, senescence biology, neurodegeneration pipelines, and immune aging
- Founders and CSOs from the longevity companies turning that science into diagnostics, therapeutics, and active clinical trials
- The AI and data teams building the models that will decide which interventions actually work, on which patients, and when
- Investors and operators deploying capital into the next generation of healthspan companies
No survey talks. No platitudes about "wellness." Technical depth, real data, and direct access to the people building the rails.
The field has spent twenty years generating discoveries. The next ten are about deployment. This is the room where that happens.
Find more details and check out this year's lineup HERE: https://longevitygl.org/boston/
--
This event is a part of #BOSTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.
Send any inquiries to agingcode@longevitygl.org
¬‿¬
ᵔ▾ᵔ
´◡`
Restricted Access
Verify your phone number to view event details and activity